Data · dataset · 2026
Novel lidocaine containing intraperitoneal implants for the improved control of post-surgical pain
Listed in ZivaHub and Deakin Research Online and DMU Figshare and UCL Research Data Repository — shown once because both records carry DOI 10.17034/32633046.v1
The objective of this thesis was to explore alternative ways for sustainable intraperitoneal administration of lidocaine (LID) for pain relief following an abdominal surgery.
Description
Thus, pre-formulations of eutectic mixtures (EMs) of LID with lipids (mono and di-carboxylic fatty acids or fatty alcohols) prepared in chapter 3 were further applied in three different platforms in order to improve the physical stability of drug and prolong the therapeutic effect of LID.The LID-lipids were characterised using DSC, PXRD, HSM and FTIR for EMs screening.
LID-monocarboxylic FAs and LID-fatty alcohols formed EMs whereas LID-dicarboxylic FAs did not; via HSM studies, only LID-dicarboxylic FAs showed multiple eutectic interface zones in Koffler contact method. Moreover, LID-short chain monocarboxylic FAs systems were the only binary systems which interface zones did not crystallise even at temperatures lower as -90 oC for the systems were low crystallisation tendency. Thus, LID-monocarboxylic FAs and LID-fatty alcohols binary mixtures were carried forward to design novel delivery systems.
Read the rest (2 more)
First, selected EMs were incorporated into (1), oil-in-water emulsions (chapter 4), (2), solid dispersions (SDs) with polyethylene oxide (PEO), (water soluble polymer) (chapter 6) and (3) in solid dispersions with poly(ethylene vinyl acetate) (EVA) (insoluble polymer) (chapter 7).In chapter 5 a relationship of LID and other 3 LAs namely, prilocaine (PRL), ropivacaine (ROP) and mepivacaine (MPV) was investigated by screening their potential to form eutectic mixtures with same series of lipids used in chapter 3.
In vitro drug release studies from Pluronic F-127 based o/w formulations, showed drug release for maximum two days before adding NaCl into formulation: however, the LID release prolonged for about 7 days after addition of NaCl. LID-lipids/PEO ternary solid implants prolonged drug release for maximum 7 days whereas LID-lipids/EVA controlled the drug release for even longer period.<br>
Links
Where it is published
- DOI doi.org/10.17034/32633046.v1 ↗
DOI / persistent id · from zivahub uct ac za
Catalogue records · 1
- OAI-PMH record api.figshare.com/v2/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Af… ↗
metadata API · from zivahub uct ac za
Topics
Provenance · 4 source records, 8 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| ZivaHub | oai:figshare.com:article/32633046 | 11 d ago | JSON v1 |
| Deakin Research Online | oai:figshare.com:article/32633046 | 11 d ago | JSON v1 |
| DMU Figshare | oai:figshare.com:article/32633046 | 11 d ago | JSON v1 |
| UCL Research Data Repository | oai:figshare.com:article/32633046 | 11 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| concepts[field].local:field:earth-environmental | mapping · rdr ucl ac uk | connector:rdr_ucl_ac_uk@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · dro deakin edu au | connector:dro_deakin_edu_au@1.0.0 | |
| concepts[field].local:field:earth-environmental | mapping · figshare dmu ac uk | connector:figshare_dmu_ac_uk@1.0.0 | |
| description | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/description |
| license_text | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| publication_date | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | |
| title | source · zivahub uct ac za | connector:zivahub_uct_ac_za@1.0.0 | /metadata/dc/title |